SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001461790-23-000009
Filing Date
2023-02-13
Accepted
2023-02-13 16:32:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SPRY_13G_20230213.htm SC 13G/A 105090
  Complete submission text file 0001461790-23-000009.txt   106698
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Subject) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91894 | Film No.: 23619044
SIC: 2834 Pharmaceutical Preparations